Target Name: MRPS31
NCBI ID: G10240
Review Report on MRPS31 Target / Biomarker Content of Review Report on MRPS31 Target / Biomarker
MRPS31
Other Name(s): 28S ribosomal protein S31, mitochondrial | IMOGN38 | mitochondrial small ribosomal subunit protein mS31 | Mitochondrial small ribosomal subunit protein mS31 | imogen 38 | mitochondrial ribosomal protein S31 | MRP-S31 | Imogen 38 | Mitochondrial ribosomal protein S31 | S31mt | RT31_HUMAN

MRPS31: A Potential Drug Target and Biomarker for Mitochondrial Function

Abstract:

Mitochondrial ribosomal protein S31 (MRPS31) is a protein that plays a crucial role in the regulation of mitochondrial function and metabolism. It is composed of 28 amino acids and has a calculated molecular weight of 31 kDa. Although it is involved in various cellular processes, its functions and mechanisms of action remain poorly understood. However, recent studies have identified its potential as a drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. In this article, we will explore the biology and functions of MRPS31, its potential drug targets, and its potential as a biomarker for disease diagnosis and treatment.

Introduction:

Mitochondria are organelles that are responsible for generating energy in the form of ATP during cellular processes. They are also involved in the regulation of various cellular processes, including metabolism, stress response, and disease development. Ribosomal proteins (RPs) are a class of proteins that are synthesized in the cytoplasm and functions to synthesize proteins for the cell. Mitochondrial RPs play a crucial role in regulating mitochondrial function and metabolism.

MRPS31 is a protein that is expressed in the mitochondria and is involved in various cellular processes. It is a 28S RP and has a calculated molecular weight of 31 kDa. It is composed of 28 amino acids and has a single polypeptide chain. MRPS31 is a protein that is expressed in various cell types, including muscle, heart, liver, and brain. It is also expressed in the cytoplasm of various cell types and is involved in various cellular processes, including metabolism, stress response, and disease development.

Potential Drug Targets:

MRPS31 has been identified as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. Its functions and mechanisms of action remain poorly understood, but recent studies have identified its potential as a drug target.

1. Cancer:

MRPS31 has been shown to be involved in various cellular processes that are associated with cancer development. It is involved in cell signaling, DNA replication, and apoptosis. Studies have shown that MRPS31 can inhibit the growth of cancer cells and induce cell apoptosis. Therefore, MRPS31 may be a useful drug target for cancer treatment.

1. Neurodegenerative Diseases:

MRPS31 is involved in various cellular processes that are associated with neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Studies have shown that MRPS31 may be involved in the development and progression of neurodegenerative diseases. Therefore, MRPS31 may be a useful biomarker for neurodegenerative diseases and a potential drug target for disease treatment.

1. Metabolic Disorders:

MRPS31 is involved in various cellular processes that are associated with metabolic disorders, including diabetes, obesity, and hypothyroidism. Studies have shown that MRPS31 may be involved in the development and progression of metabolic disorders. Therefore, MRPS31 may be a useful biomarker for metabolic disorders and a potential drug target for disease treatment.

Potential Biomarkers:

MRPS31 may also be used as a biomarker for various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. Its functions and mechanisms of action remain poorly understood, but recent studies have identified its potential as a biomarker for disease diagnosis and

Protein Name: Mitochondrial Ribosomal Protein S31

The "MRPS31 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MRPS31 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MRPS31P2 | MRPS31P4 | MRPS31P5 | MRPS33 | MRPS33P4 | MRPS34 | MRPS35 | MRPS35-DT | MRPS36 | MRPS36P4 | MRPS5 | MRPS6 | MRPS7 | MRPS9 | MRRF | MRS2 | MRS2P2 | MRTFA | MRTFB | MRTO4 | MS4A1 | MS4A10 | MS4A12 | MS4A13 | MS4A14 | MS4A15 | MS4A18 | MS4A2 | MS4A3 | MS4A4A | MS4A4E | MS4A5 | MS4A6A | MS4A6E | MS4A7 | MS4A8 | MSANTD1 | MSANTD2 | MSANTD3 | MSANTD4 | MSC | MSC-AS1 | MSGN1 | MSH2 | MSH3 | MSH4 | MSH5 | MSH5-SAPCD1 | MSH6 | MSI1 | MSI2 | MSL1 | MSL2 | MSL3 | MSL3P1 | MSLN | MSLNL | MSMB | MSMO1 | MSMP | MSN | MSNP1 | MSR1 | MSRA | MSRA-DT | MSRB1 | MSRB1P1 | MSRB2 | MSRB3 | MSRB3-AS1 | MSS51 | MST1 | MST1L | MST1P2 | MST1R | MSTN | MSTO1 | MSTO2P | MSX1 | MSX2 | MSX2P1 | MT1A | MT1B | MT1DP | MT1E | MT1F | MT1G | MT1H | MT1HL1 | MT1IP | MT1JP | MT1L | MT1M | MT1P1 | MT1P3 | MT1X | MT1XP1 | MT2A | MT3 | MT4